Results 81 to 90 of about 15,641 (133)

Combined [ 223 Ra]Radiumdichloride and [ 177 Lu]Lu-PSMA-617 Therapy in End-stage Metastatic Castration-resistant Prostate Cancer. [PDF]

Clin Nucl Med
Hügle MJ, Patt M, Dierks A, Steinestel J, Lapa C.   +4 more
europepmc   +1 more source

TLN1 interacts with NGFR and suppresses the development of castration-resistant prostate cancer by upregulating NGFR. [PDF]

Front Immunol
Li S, Chen A, Guo C, Gu C, Tang Z, Shen S, Yang D, Mi Y.   +7 more
europepmc   +1 more source

Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohort. [PDF]

BMC Cancer
Wenzel M, Filzmayer M, Siech C, Le QC, Lauer B, Theissen L, Hoeh B, Heinzer H, Graefen M, Steuber T, Kriegmair M, Chun FK, Mandel P.   +12 more
europepmc   +1 more source

Oligometastatic Prostate Cancer: Clues from an N-of-1. [PDF]

J Clin Med
Kirschenbaum A, Verma P, Cheung P, Yao S, Drummond C, Tipi I, Yao A, Levine AC.   +7 more
europepmc   +1 more source

Metastasis of Castration-Resistant Prostate Adenocarcinoma to the Lacrimal Gland: A Case Report. [PDF]

Reports (MDPI)
Milic N, Lojanica MV, Ivanovic M, Matijasevic M, Ivanovic S.   +4 more
europepmc   +1 more source

The Role of Gut Microbiome in Prostate Cancer: Current Evidence and Emerging Opportunities. [PDF]

Cancers (Basel)
Huang J, Zhu XH, Trotman LC, Tsao CK.
europepmc   +1 more source

Impact of PSMA-Based Radiopharmaceuticals on the Clinical Management of Prostate Cancer. [PDF]

Cancers (Basel)
Guida C, Evangelista L, Spadafora M, Facchini G, Mansi L.   +4 more
europepmc   +1 more source

Comparative Digital Estrogen Receptor Alpha (ERα) Expression Analysis in Benign and Malignant Prostate Tissue of Men and Dogs. [PDF]

Prostate
Lothion-Roy J, Aeschlimann L, Hiller LA, Rottenberg S, Mongan NP, Rutland CS, Rakha E, Dean A, Rubin MA, de Brot S.   +9 more
europepmc   +1 more source